Status epilepticus associated with Mycoplasma pneumoniae encephalitis in children: good prognosis following early diagnosis and treatment
Mycoplasma pneumoniae is one of the most common bacteria causing respiratory infections in kids—think coughs, fevers, and sore throats. But few parents know this microbe can also harm the brain, leading to severe seizures called status epilepticus. A 2019 study from Beijing’s Capital Institute of Pediatrics offers hope: early diagnosis and treatment can drastically improve outcomes for children with this rare but dangerous combination of conditions.
What is Mycoplasma pneumoniae encephalitis?
Mycoplasma pneumoniae infects millions of children yearly, typically causing mild to moderate respiratory illness. But in 5–7% of cases, the bacteria triggers immune-related damage in other organs—including the central nervous system (CNS), according to a 2006 review in Current Opinion in Neurology. When the brain is inflamed (a condition called encephalitis), symptoms range from headaches to seizures. For some kids, this leads to status epilepticus—a life-threatening emergency where seizures last over 5 minutes or repeat without the child regaining consciousness.
While Mycoplasma pneumoniae encephalitis is well-documented, there are few reports on how it interacts with status epilepticus in children. That’s where the 2019 study comes in: researchers from the Children’s Hospital Affiliated to Capital Institute of Pediatrics analyzed four kids with both conditions to understand their symptoms, tests, treatments, and recovery.
Study details: Who was included?
The study focused on three boys and one girl, aged 3 to 8, admitted between July 2017 and June 2018. All had acute onset of illness:
- High fevers (39–40°C, 2–4 times a day)
- Two reported coughs (a classic Mycoplasma symptom)
- Three had impaired consciousness (Glasgow Coma Scale 11–12, meaning confusion or drowsiness)
- One was fully unconscious
Their seizures varied:
- Myoclonus (muscle jerks) after tonic-clonic seizures (whole-body stiffness and jerking)
- Generalized tonic-clonic seizures (full-body)
- Complex partial seizures (staring, confusion)
- Tonic-clonic seizures plus abnormal brain electrical activity without visible symptoms
How was it diagnosed?
Doctors used three key tests to confirm Mycoplasma pneumoniae encephalitis:
- Lumbar puncture (spinal tap): Done 4–14 days after symptoms started, this test checks cerebrospinal fluid (CSF)—the fluid around the brain and spine. All four kids tested positive for Mycoplasma pneumoniae RNA (genetic material), while other pathogens (viruses, bacteria, fungi) were negative. Routine CSF tests (cell count, protein, glucose) were normal.
- Video EEG: Measures brain activity. All kids had slow-wave backgrounds (a sign of inflammation). Three had epileptiform discharges (abnormal spikes linked to seizures) in multiple brain areas; one had persistent spikes in the frontal lobes.
- MRI: Scans showed abnormalities in three kids:
- Two had changes in the hippocampus (the brain’s memory center)
- One had demyelination (damage to the protective coating around nerve fibers)
- The fourth had no clear issues initially, but all later showed mild brain atrophy (shrinkage) on follow-up scans.
Treatment and recovery
All four children received azithromycin—a macrolide antibiotic that targets Mycoplasma pneumoniae—for two weeks (5 days a week). Additional treatments included:
- Dexamethasone: A steroid to reduce inflammation (given to 3 kids)
- Intravenous immunoglobulin (IVIG): A blood product that boosts the immune system (given to 2 kids)
- One child got both IVIG and dexamethasone
The results were promising:
- Fever resolved in all kids within weeks.
- Consciousness improved: Three of the four (including the initially unconscious child) regained full awareness.
- Seizures controlled: Two stopped having seizures entirely. The other two took oral levetiracetam and topiramate to lower seizure frequency.
- Brain activity improved: Follow-up EEGs still showed slow waves but had far fewer epileptiform discharges.
- No severe cognitive harm: While MRI scans revealed mild brain atrophy, none of the kids had noticeable learning or thinking issues—a major win.
Why early treatment matters
Previous research painted a grim picture: 41–48% of kids with Mycoplasma pneumoniae encephalitis have seizures, and half of those are status epilepticus (per studies in Epilepsia and European Journal of Clinical Microbiology & Infectious Diseases). Surviving children often face long-term neurological problems, with 47% developing post-encephalitic epilepsy (per a 2010 study in Pediatric Neurology).
This study’s outcomes were better because of early intervention. Researchers found that Mycoplasma pneumoniae causes harm in two ways: direct infection and an overactive immune response. By combining antibiotics (to kill the bacteria) with steroids/IVIG (to calm inflammation), doctors stopped damage before it became permanent.
Key takeaways for parents and doctors
- Young kids are at risk: The study’s participants were preschool-aged (3–8), a group more vulnerable to severe Mycoplasma complications.
- Watch for red flags: If your child has a Mycoplasma infection and develops seizures, confusion, or loss of consciousness, seek emergency care immediately.
- Early diagnosis saves lives: Testing CSF for Mycoplasma pneumoniae RNA (not just blood tests) is critical—this study’s kids were diagnosed quickly because their CSF was positive for the bacteria.
- Combo treatment works: Antibiotics alone aren’t enough. Immunotherapy (steroids or IVIG) helps address the immune system’s role in brain damage.
What does this mean for the future?
While the study included only four children, its findings highlight the power of early action. For kids with Mycoplasma pneumoniae encephalitis and status epilepticus, timely treatment can mean the difference between long-term disability and a full (or nearly full) recovery.
This article is based on research published in the Chinese Medical Journal (2019) by Shuo Feng, Jin-Xiao Chen, Ping Zheng, Jian-Zhao Zhang, Zhi-Jie Gao, Ying-Ying Mao, Xin-Na Ji, Shu-Hua Chen, Hong-Mei Sun, and Qian Chen from the Department of Neurology at the Children’s Hospital Affiliated to Capital Institute of Pediatrics, Beijing.
doi.org/10.1097/CM9.0000000000000233
Was this helpful?
0 / 0